Real-Life Treatment Paradigms Show Adalimumab Is Cost-Effective for the Management of Ulcerative Colitis

Background. Adalimumab is effective for the maintenance of remission in patients with moderate-to-severe ulcerative colitis (UC). Currently, biologic therapies are used in cases where patients fail conventional medical therapies. If biologic therapies are not available, patients often choose to rema...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Can J Gastroenterol Hepatol
Glavni autori: Beilman, Candace L., Thanh, Nguyen Xuan, Ung, Victoria, Ma, Christopher, Wong, Karen, Kroeker, Karen I., Lee, Thomas, Wang, Haili, Ohinmaa, Arto, Jacobs, Phil, Halloran, Brendan P., Fedorak, Richard N.
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2016
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5065999/
https://ncbi.nlm.nih.gov/pubmed/27781203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/5315798
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items